- Home
- MVO vs INMB Comparison
MVO vs INMB Comparison
Compare MVO & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVO
- INMB
- Stock Information
- Founded
- MVO 2006
- INMB 2015
- Country
- MVO United States
- INMB United States
- Employees
- MVO N/A
- INMB N/A
- Industry
- MVO Oil & Gas Production
- INMB Biotechnology: Pharmaceutical Preparations
- Sector
- MVO Energy
- INMB Health Care
- Exchange
- MVO Nasdaq
- INMB Nasdaq
- Market Cap
- MVO 95.7M
- INMB 103.1M
- IPO Year
- MVO N/A
- INMB 2019
- Fundamental
- Price
- MVO $7.18
- INMB $6.53
- Analyst Decision
- MVO
- INMB Strong Buy
- Analyst Count
- MVO 0
- INMB 2
- Target Price
- MVO N/A
- INMB $21.00
- AVG Volume (30 Days)
- MVO 55.1K
- INMB 369.6K
- Earning Date
- MVO 01-01-0001
- INMB 10-31-2024
- Dividend Yield
- MVO 17.46%
- INMB N/A
- EPS Growth
- MVO N/A
- INMB N/A
- EPS
- MVO 1.46
- INMB N/A
- Revenue
- MVO N/A
- INMB $42,000.00
- Revenue This Year
- MVO N/A
- INMB N/A
- Revenue Next Year
- MVO N/A
- INMB N/A
- P/E Ratio
- MVO $7.29
- INMB N/A
- Revenue Growth
- MVO N/A
- INMB N/A
- 52 Week Low
- MVO $8.85
- INMB $4.32
- 52 Week High
- MVO $13.95
- INMB $14.74
- Technical
- Relative Strength Index (RSI)
- MVO 30.44
- INMB 64.22
- Support Level
- MVO $8.31
- INMB $6.04
- Resistance Level
- MVO $8.87
- INMB $6.83
- Average True Range (ATR)
- MVO 0.33
- INMB 0.56
- MACD
- MVO -0.07
- INMB 0.17
- Stochastic Oscillator
- MVO 1.74
- INMB 86.76
About MVO MV Oil Trust Units of Beneficial Interests
MV Oil Trust is a statutory trust. Its underlying properties consist of MV Partners, LLC's (MV Partners) net interests in all of its oil and natural gas properties, which are located in the Mid-Continent region in the States of Kansas and Colorado. These oil and gas properties include producing oil and gas wells.
About INMB INmune Bio Inc. Common stock
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.